Robert Kushner, MD, MS, professor of medicine and medicine education at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, sat down with Drug Topics ahead of the American Society for Preventive Cardiology Congress on CVD Prevention to discuss the benefits of glucagon-like peptide-1 (GLP-1) therapies and highlighted some strategies for management of adverse effects
Mitochondria are specialized membrane-bound organelles that play key roles in iron metabolism in that they synthesize heme, assemble iron-sulfur proteins, and are involved in the cellular iron regulation
The European Medicines Agency (EMA) has reviewed reports of suicidal or self-injurious thoughts among GLP-1 users worldwide

GLP-1 Receptor Agonist Cardiovascular Therapy Market Report Scope: Market Segmentation: GLP-1 Receptor Agonist Cardiovascular Therapy Market by Indication- Atherosclerotic Cardiovascular Disease Heart Failure with Preserved Ejection Fraction Neurological Indications Chronic Kidney Disease GLP-1 Receptor Agonist Cardiovascular Therapy Market by Drug Class- GLP-1/GIP Dual Agonists GLP-1 Mono-Agonists GLP-1/Amylin Combinations GLP-1 Receptor Agonist Cardiovascular Therapy Market by End-user- Cardiologists Hospital Systems Primary Care Physicians Endocrinologists GLP-1 Receptor Agonist Cardiovascular Therapy Market By Region- North America- The US Canada Europe- Germany The UK France Italy Spain Rest of Europe Asia-Pacific- China Japan India South Korea South East Asia Rest of Asia Pacific Latin America- Brazil Argentina Mexico Rest of Latin America Middle East & Africa- GCC Countries South Africa Rest of Middle East and Africa Research Design and Approach This study employed a multi-step, mixed-method research approach that integrates: Secondary research Primary research Data triangulation Hybrid top-down and bottom-up modelling Forecasting and scenario analysis This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market

Skinner Asheley, C., Perrin Eliana, M., Moss Leslie, A